WCC Biomedical
PrivateLast Round
Series C
Sep 1, 2024
Total Funding Raised
$23.09M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
WCC Biomedical is a biotechnology company that specializes in the development and manufacturing of microarray patches (MAPs) for pharmaceutical, vaccine, and cosmetic applications using its proprietary WINMAP technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Fashion & Beauty, D2C Brands
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WCC Biomedical Comparables
Compare WCC Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Raphas | 85% | |
| Terrestrial Bio | 83% | |
| Innoture | 83% |
WCC Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2024 | ||||
| Series B | Jun 14, 2023 | ||||
| Series A | Feb 1, 2022 | ||||
| Grant | Jun 1, 2019 |
WCC Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Science and Technology Council | Grant |
| CTBC Venture Capital | Series B |
| Taiwan Cooperative Venture Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 69% MoM, reaching 903.
- Nov 9, 2025
Monthly visitors increased 76% month-over-month.
WCC Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about WCC Biomedical's valuation, stock price, and market status.
Is WCC Biomedical a public or private company?
WCC Biomedical is a private company.
What is the current stock price of WCC Biomedical?
WCC Biomedical is a private company, so its shares have no public market price. Caplight tracks WCC Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is WCC Biomedical worth (valuation)?
Valuation information for WCC Biomedical is not publicly available.
Can I buy WCC Biomedical stock?
WCC Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was WCC Biomedical's last funding round?
WCC Biomedical's most recent funding round was Series C on September 1, 2024.
Who are the main investors in WCC Biomedical?
Key investors in WCC Biomedical include National Science and Technology Council, CTBC Venture Capital, Taiwan Cooperative Venture Capital.
Will WCC Biomedical IPO soon?
No public IPO plans have been announced for WCC Biomedical.
How can I track WCC Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in WCC Biomedical's shares on secondary markets.